Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Hygromycin by Flightpath BioSciences for Lyme Disease: Likelihood of Approval
Hygromycin is under clinical development by Flightpath BioSciences and currently in Phase I for Lyme Disease. According to GlobalData, Phase...